Advances in treatment of myocardial infarction by mesenchymal stem cell transplantation / 生物医学工程学杂志
Journal of Biomedical Engineering
;
(6): 939-944, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-234480
ABSTRACT
Mesenchymal stem cells(MSCs)is a kind of non hematopoietic stem cell from the mesoderm, which can self renew, proliferate and perform multilineage differentiation. Due to the characteristics of acquiring easily and low immunogenicity, it has become the main cell for myocardial infarction. In this article, the biology and the immunology of the MSCs is reviewed, the safety and the validity of the therapy on myocardial infarction with MSCs and the HGF/MSCs is introduced. And furthermore, it also explains the possible mechanism and the problems of how to improve the cardial function.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Terapéutica
/
Células Madre Hematopoyéticas
/
Diferenciación Celular
/
Trasplante de Células Madre Mesenquimatosas
/
Células Madre Mesenquimatosas
/
Infarto del Miocardio
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Biomedical Engineering
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS